Past Event

Should we revisit the patent system for pharmaceutical products?

Analysis of the legal issues with the current IP system for regulated market authorisations for pharmaceutical products, as well as its economic effects.

Date: July 9, 2018, 12:30 pm Topic: Innovation & Competition Policy

video & audio recordings

summary

The panel set themselves to address some fundamental questions about the European patent system and how it affects the pharmaceutical sector, as the pharmaceutical industry represents roughly 30% of all the EU R&D spending. They discussed the proposal put forward by the Commission about a reform of the supplementary protection certificate, which extends pharmaceutical companies’ patent protection for an additional 5 years maximum as a compensation for the years of patent term lost for the development of the patented product prior to effective market entry. In order to boost jobs creation in generics and biosimilars manufacturing and to alleviate some of the concerns about access to medicines, the reform would introduce a waiver for generic and biosimilar manufacturers’ exports outside the EU. This would allow them to manufacture generic and biosimilar versions of protected products and to sell them abroad without fees to patent-owners. The private sector is however concerned this initiative reduces IP rights, while recognizing the Commission’s efforts to introduce safeguards with regards to labelling and stockpiling.

The panel then discussed two studies that explored the legal and economic aspects of the proposed reforms. Economically, intellectual property protection in the pharmaceutical industry is found to incentivise innovation, but is negative for access to the molecules developed. Indeed, protection results in a significantly higher price compared to when competition from generic versions of the products enter the market. From a legal perspective, the reform is found to be necessary as the Court of Justice of the EU has taken decisions that have led to a divergence from the legal basis: reducing that divergence, either by codifying case law or addressing the ambiguities in the legal basis.

Participants then discussed some of the shortcomings of the current patent system in general. Some of the key issues of the current systems on which most participants seem to agree was the need to unify the EU intellectual property framework and the need to consider the global aspect of intellectual property legislation. Indeed, participants agreed that the current system is very fragmented, with 28 regulators, 28 sets of rules and 28 times the amount of administrative costs – for 28 nations that aspire to form a single market, this was perceived as inefficient. Furthermore, participants mentioned how other nations’ own legislative templates were influenced by the EU’s system and that there existed international agreements. These therefore limit the degrees of freedom the EU has to reform. However, the pharmaceutical industry clarified that duration of intellectual property protection was generally not a factor in selecting a location for establishing activities.

More broadly, participants and the audience discussed how other incentives for innovation in the EU had been left out of the debate, as well as fundamental problems. Because the real benefits of innovation cannot be known ex ante, intellectual property protection has always been a sort of trade-off between incentivisation and access. There was an agreement that, in addition of the traditional patent protection, other incentivisation mechanisms should be better leveraged for innovation, such as public funding for research, prizes, Europe-wide industrial policy, pricing policy or universities’ royalty system. In terms of more fundamental reforms of the patenting system, the audience suggested thinking of a system that factors in the profitability of innovation rather than merely the revenue side. They also highlighted the need to tackle “fake innovation” and abuse of the intellectual property system that stymies innovation, noting the importance of having transparent system with clear criteria for granting protection.

event materials

Study on the economic impact of supplementary protection certificates, pharmaceutical incentives and rewards in Europe, by Copenhagen Economics (call for tender 590/PP/GRO/SME/16/F/121)

Schedule

Jul 9, 2018

12:30-13:00

Check-in and lunch

13:00-14:00

Panel discussion

Chair: Reinhilde Veugelers, Senior Fellow

Arno Hartmann, Member of EFPIA's IP expert group

Christian Jervelund, Head Health Care and Life Sciences services, Copenhagen Economics

Margaret K. Kyle, Professor of Economics, Center for Industrial Economics (CERNA), MINES ParisTech (Ecole des Mines)

Roberto Romandini, Senior Research Fellow, Max Planck Institute for Innovation and Competition

Amaryllis Verhoeven, Head of Unit, Industrial Property and the Fight against Counterfeiting, European Commission

Bruno van Pottelsberghe, Non-Resident Fellow

14:00-14:30

Q&A

14:30

End

Speakers

Arno Hartmann

Member of EFPIA's IP expert group

Christian Jervelund

Head Health Care and Life Sciences services, Copenhagen Economics

Margaret K. Kyle

Professor of Economics, Center for Industrial Economics (CERNA), MINES ParisTech (Ecole des Mines)

Roberto Romandini

Senior Research Fellow, Max Planck Institute for Innovation and Competition

Bruno van Pottelsberghe

Non-Resident Fellow

Amaryllis Verhoeven

Head of Unit, Industrial Property and the Fight against Counterfeiting, European Commission

Reinhilde Veugelers

Senior Fellow

Location & Contact

Bruegel, Rue de la Charité 33, 1210 Brussels

Katja Knezevic

katja.knezevic@bruegel.org

Read about event More on this topic

Upcoming Event

Jun
7
11:00

Brussels Policy Dialogue: Insights for EU and Member States’ Climate Agenda

The event is a policy dialogue organised under the project, 'COP21: Results and Implications for Pathways and Policies for Low Emissions European Societies'.

Speakers: Artur Runge-Metzger, Oliver Sartor, Marta Torres-Gunfaus and Georg Zachmann Topic: Energy & Climate Location: Bruegel, Rue de la Charité 33, 1210 Brussels
Read about event More on this topic

Past Event

Past Event

How do national energy policies fit into EU decarbonisation plans?

Through considering several different national perspectives, we discuss how to reconcile the EU Climate Strategy targets with national energy and climate policies.

Speakers: Aleksandra Gawlikowska-Fyk, Christian von Hirschhausen, Carole Mathieu and Georg Zachmann Topic: Energy & Climate Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: May 15, 2019
Read article More by this author

Blog Post

Spitzenkandidaten visions for the future of Europe's economy

What are the different political visions for the future of Europe’s economy? Bruegel and the Financial Times organised a debate series with lead candidates from six political parties in the run-up to the 2019 European elections.

By: Giuseppe Porcaro Topic: European Macroeconomics & Governance, Global Economics & Governance, Innovation & Competition Policy Date: May 8, 2019
Read article More on this topic More by this author

Blog Post

Breaking up big companies and market power concentration

Senator Elizabeth Warren proposes the break-up of big tech companies. A report for the UK government presents another approach for regulating the digital economy. And IMF research serves as a reminder that concentration of market power extends beyond digital. This blog reviews the debate.

By: Konstantinos Efstathiou Topic: Innovation & Competition Policy Date: April 29, 2019
Read about event More on this topic

Past Event

Past Event

Spitzenkandidaten series: Frans Timmermans

The sixth event in the The Road to Europe - Brussels Briefing Live: Spitzenkandidaten series. The series features the lead candidates for the European Elections of six parties and is jointly organised by Bruegel and the Financial Times in March and April 2019.

Speakers: Mehreen Khan, André Sapir and Frans Timmermans Topic: European Macroeconomics & Governance Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: April 11, 2019
Read about event More on this topic

Past Event

Past Event

Spitzenkandidaten series: Manfred Weber

The fifth event in the The Road to Europe - Brussels Briefing Live: Spitzenkandidaten series. The series features the lead candidates for the European Elections of six parties and is jointly organised by Bruegel and the Financial Times in March and April 2019.

Speakers: Anne-Sylvaine Chassany, Manfred Weber and Guntram B. Wolff Topic: European Macroeconomics & Governance Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: April 9, 2019
Read about event More on this topic

Past Event

Past Event

Spitzenkandidaten series: Jan Zahradil

The fourth event in the The Road to Europe - Brussels Briefing Live: Spitzenkandidaten series. The series features the lead candidates for the European Elections of six parties and is jointly organised by Bruegel and the Financial Times in March and April 2019.

Speakers: Jim Brunsden, Maria Demertzis and Jan Zahradil Topic: European Macroeconomics & Governance Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: April 4, 2019
Read about event More on this topic

Past Event

Past Event

Spitzenkandidaten series: Luis Garicano

The third event in the The Road to Europe - Brussels Briefing Live: Spitzenkandidaten series. The series features the lead candidates for the European Elections of six parties and is jointly organised by Bruegel and the Financial Times in March and April 2019.

Speakers: Luis Garicano, Mehreen Khan and Guntram B. Wolff Topic: European Macroeconomics & Governance Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: April 3, 2019
Read about event More on this topic

Past Event

Past Event

Spitzenkandidaten series: Bas Eickhout

The second event in the The Road to Europe - Brussels Briefing Live: Spitzenkandidaten series. The series features the lead candidates for the European Elections of six parties and is jointly organised by Bruegel and the Financial Times in March and April 2019.

Speakers: Bas Eickhout, Guntram B. Wolff and Rochelle Toplensky Topic: European Macroeconomics & Governance Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: April 2, 2019
Read about event More on this topic

Past Event

Past Event

Rethinking industrial policy in the digital age: challenges for Europe

All-day conference about how the European policy-making will have to adapt to the digital transformation.

Speakers: Philipp-Bastian Brutscher, Teunis Brosens, Maarten Camps, Lise Fuhr, Padmashree Gehl Sampath, Andreas Geiss, Tony Graziano, Mathew Heim, Thorsten Käseberg, Thomas Kramler, Robert Kroplewski, Timothy Lamb, J. Scott Marcus, Philip Marsden, Jan Mischke, Joakim Reiter, Megan Richards, Valentino Rossi, Marietje Schaake, Reinhilde Veugelers, Guntram B. Wolff and Georg Zachmann Topic: Innovation & Competition Policy Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: March 21, 2019
Read about event More on this topic

Past Event

Past Event

A new climate strategy for the EU

At a pivotal point in time, three major EU sides come together to discuss the future climate strategy.

Speakers: Silke Karcher, Andrei Marcu, Raffaele Mauro Petriccione, Kathleen Van Brempt and Georg Zachmann Topic: Energy & Climate Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: March 19, 2019
Read about event More on this topic

Past Event

Past Event

Law and macroeconomics: legal responses to recessions

This event will feature an academic lecture on the use of law as a macroeconomic tool.

Speakers: Yair Listokin and Maria Demertzis Topic: Global Economics & Governance Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: March 12, 2019
Load more posts